Adams Respiratory Therapeutics

Adams Respiratory Therapeutics was a New Jersey-based specialty pharmaceutical company founded in 1997 that focused on developing and marketing over-the-counter and prescription medications for treating respiratory disorders such as chronic bronchitis and acute infections. Its flagship brand was Mucinex—a leading expectorant product—which it expanded into related formulations including nasal sprays shortly before being acquired by Reckitt Benckiser plc in early 2008. The company operated primarily within the U.S., had an estimated workforce ranging from several dozen up to about five hundred employees at peak size prior to its integration into Reckitt's global operations.